V V Zakharov (V V Zaharov)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Antiplatelet Therapy

Cognitive Impairment

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

This page only lists publications with an associated author ORCID identifier.

Publications

V V Zakharov, N V Vakhnina
[The use of Mexidol in patients with mild (moderate) cognitive impairment: results of a meta-analysis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (1) (2024)
O O Martynova, V V Zakharov
[Impairment of attention and executive functions in chronic cerebrovascular disease and Alzheimer's disease]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4. Vyp. 2) (2024)
V V Zakharov, P A Chernousov, K A Vekhova, A N Bogolepova
[Cognitive impairment in patients with arterial hypertension]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4. Vyp. 2) (2024)
V V Zakharov, P A Chernousov, K A Vekhova, A N Bogolepova
[Cognitive impairment in patients with arterial hypertension]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 124 (4. Vyp. 2) (2024)
M S Novikova, V V Zakharov
[Predictors of the efficacy of non-drug treatments for non-dementia vascular cognitive impairment]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (5) (2023)
V V Zakharov, A I Fedin, E A Mhitaryan
[Pharmacotherapy approaches to vascular mild cognitive impairment in patients of different age groups]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (10) (2023)
O S Levin, V V Zakharov, K K Khacheva, A L Vladykin, A A Globenko
[Pathogenetic therapy of cognitive impairment: results of a multicenter placebo-controlled clinical trial of the efficacy and safety of Miladean]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (10) (2023)
A N Bogolepova, V V Zakharov, Sergey Nikolaevich Illarioshkin, I A Litvinenko, E A Mhitaryan, N V Pizova, E Z Yakupov
[Diagnosis and treatment of early forms of cognitive impairment: possibilities of influencing neuronal energy metabolism. Resolution of the Council of Experts]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 123 (9) (2023)
M A Cherdak, E A Mhitaryan, V V Zakharov, Nikolay Voznesenskiy
[Vitamin B12 in the treatment and prevention of cognitive disorders in the elderly]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (1) (2022)
L A Edilgireeva, T A Sadulaeva, V V Zakharov, N V Vakhnina
[The effect of antiplatelet therapy on the course of COVID-19]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (3) (2022)
I A Voznjouk, V V Zakharov, M M Tanashyan, M V Putilina, S A Zhivolupov, O V Vorobieva, M A Granovskaya, Alexey B Danilov, Andrey Danilov, V N Shishkova, N V Pizova, I A Litvinenko, Polina I Kuznetsova, Anton A Raskurazhev, V V Butsev
[Prospects of use of research results for drugs with anitihypoxic and antioxidative properties in neuroprotective treatment strategies (Opinion of the Council of Experts dated 26 March 2022)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (7) (2022)
V V Zakharov, I V Borodulina, N V Vakhnina
[Treatment of patients with chronic cerebral ischemia: experience of using the combined neuroprotective drug Picamilon Ginkgo]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (9) (2022)
V V Zakharov, Olga N Tkacheva, E A Mhitaryan, A I Fedin
[Efficacy of Mexidol in patients with chronic brain ischemia and cognitive impairment of different age groups (results of sub-analysis of the international multicenter, randomized, double-blind, placebo-controlled study of sequential therapy in patients with chronic brain ischemia MEMO)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (11. Vyp. 2) (2022)
V V Zakharov
[Effects of Logacer in patients with chronic brain ischemia and moderate cognitive impairment: results of non-interventional clinical observation]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (6) (2022)
A I Fedin, V V Zakharov, M M Tanashyan, E I Chukanova, E N Madzhidova, L A Shchepankevich, Olga Dmitrievna Ostroumova
[Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (11) (2021)
D E Vybornykh, V V Zakharov, E G Gemdzhian, Mikhail Yu Drokov, S Yu Fedorova, S O Khrushchev
[Predictors of severe lesions of the central nervous system in the treatment of blood system diseases]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (11) (2021)
E V Yekusheva, Evgenia V Shikh, A S Ametov, Olga Dmitrievna Ostroumova, V V Zakharov, S A Zhivolupov, Wende Tian
[The problem of vitamin B12 deficiency: relevance, diagnosis and targeted therapy (based on materials of an interdisciplinary expert council with international participation)]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (11) (2021)
G E Ivanova, A N Bogolepova, O S Levin, N A Shamalov, Dina R Khasanova, S N Yanishevskij, V V Zakharov, S E Khat'kova, L V Stakhovskaya
[Current issues of treatment and rehabilitation of patients with neurological disorders and the consequences of COVID-19. Resolution of Advisory Board]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (6) (2021)
V V Zakharov, N V Vakhnina, A G Gogoleva
[The criteria for effectiveness of reperfusion therapy and neuroprotective therapy in ischemic stroke]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (4) (2021)